Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 6, 1231-1240, 08 May 2008
doi:10.1016/j.ajhg.2008.04.006
Article
Ana M. Valdes1,
,
, John Loughlin2, 3, Kirsten M. Timms4, Joyce J.B. van Meurs5, Lorraine Southam2, Scott G. Wilson6, Sally Doherty7, Rik J. Lories8, Frank P. Luyten8, Alexander Gutin4, Victor Abkevich4, Dongliang Ge9, Albert Hofman10, André G. Uitterlinden5, 10, Deborah J. Hart1, Feng Zhang1, Guangju Zhai1, Rainer J. Egli2, Michael Doherty7, Jerry Lanchbury4 and Tim D. Spector1
1 Twin Research Unit, St. Thomas' Hospital Campus, Kings College London School of Medicine, London SE1 7EH, UK
2 University of Oxford, Institute of Musculoskeletal Sciences, Oxford OX3 7LD, UK
3 Newcastle University, Institute of Cellular Medicine, Newcastle upon Tyne NE1 7RU, UK
4 Myriad Genetics, Inc., Salt Lake City, UT 84108, USA
5 Department of Internal Medicine, Erasmus Medical Center, Rotterdam 3015 GE, The Netherlands
6 School of Medicine & Pharmacology, University of Western Australia and Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands 6009 WA, Australia
7 Academic Rheumatology, University of Nottingham, City Hospital Nottingham, Nottingham NG5 1PB, UK
8 Laboratory for Skeletal Development and Joint Disorders, Division of Rheumatology, Department of Musculoskeletal Sciences, Katholieke Universiteit Leuven, Leuven 3000, Belgium
9 Center for Population Genomics and Pharmacogenetics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710, USA
10 Department of Epidemiology & Biostatistics, Erasmus MC Rotterdam, Rotterdam 3015 GE, The Netherlands
Corresponding authorAbstract
Osteoarthritis (OA), the most prevalent form of arthritis in the elderly, is characterized by the degradation of articular cartilage and has a strong genetic component. Our aim was to identify genetic variants involved in risk of knee OA in women. A pooled genome-wide association scan with the Illumina550 Duo array was performed in 255 controls and 387 cases. Twenty-eight variants with p < 1 × 10−5 were estimated to have probabilities of being false positives ≤0.5 and were genotyped individually in the original samples and in replication cohorts from the UK and the U.S. (599 and 272 cases, 1530 and 258 controls, respectively). The top seven associations were subsequently tested in samples from the Netherlands (306 cases and 584 controls). rs4140564 on chromosome 1 mapping 5′ to both the PTGS2 and PLA2G4A genes was associated with risk of knee OA in all the cohorts studied (overall odds ratio ORmh = 1.55 95% C.I. 1.30–1.85, p < 6.9 × 10−7). Differential allelic expression analysis of PTGS2 with mRNA extracted from the cartilage of joint-replacement surgery OA patients revealed a significant difference in allelic expression (p < 1.0 × 10−6). These results suggest the existence of cis-acting regulatory polymorphisms that are in, or near to, PTGS2 and in modest linkage disequilibrium with rs4140564. Our results and previous studies on the role of the cyclooxygenase 2 enzyme encoded by PTGS2 underscore the importance of this signaling pathway in the pathogenesis of knee OA.
| A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes The American Journal of Human Genetics, Volume 80, Issue 2, 1 February 2007, Pages 273-290 Michele Cargill, Steven J. Schrodi, Monica Chang, Veronica E. Garcia, Rhonda Brandon, Kristina P. Callis, Nori Matsunami, Kristin G. Ardlie, Daniel Civello, Joseph J. Catanese, Diane U. Leong, Jackie M. Panko, Linda B. McAllister, Christopher B. Hansen, Jason Papenfuss, Stephen M. Prescott, Thomas J. White, Mark F. Leppert, Gerald G. Krueger and Ann B. Begovich Abstract We performed a multitiered, case-control association study of psoriasis in three independent sample sets of white North American individuals (1,446 cases and 1,432 controls) with 25,215 genecentric single-nucleotide polymorphisms (SNPs) and found a highly significant association with an IL12B 3′-untranslated-region SNP (rs3212227), confirming the results of a small Japanese study. This SNP was significant in all three sample sets (odds ratio [OR]common 0.64, combined P [Pcomb]=7.85×10−10). A Monte Carlo simulation to address multiple testing suggests that this association is not a type I error. The coding regions of IL12B were resequenced in 96 individuals with psoriasis, and 30 additional IL12B-region SNPs were genotyped. Haplotypes were estimated, and genotype-conditioned analyses identified a second risk allele (rs6887695) located ∼60 kb upstream of the IL12B coding region that exhibited association with psoriasis after adjustment for rs3212227. Together, these two SNPs mark a common IL12B risk haplotype (ORcommon 1.40, Pcomb=8.11×10−9) and a less frequent protective haplotype (ORcommon 0.58, Pcomb=5.65×10−12), which were statistically significant in all three studies. Since IL12B encodes the common IL-12p40 subunit of IL-12 and IL-23, we individually genotyped 17 SNPs in the genes encoding the other chains of these cytokines (IL12A and IL23A) and their receptors (IL12RB1, IL12RB2, and IL23R). Haplotype analyses identified two IL23R missense SNPs that together mark a common psoriasis-associated haplotype in all three studies (ORcommon 1.44, Pcomb=3.13×10−6). Individuals homozygous for both the IL12B and the IL23R predisposing haplotypes have an increased risk of disease (ORcommon 1.66, Pcomb=1.33×10−8). These data, and the previous observation that administration of an antibody specific for the IL-12p40 subunit to patients with psoriasis is highly efficacious, suggest that these genes play a fundamental role in psoriasis pathogenesis. Abstract | | |
| Identification of a Role for the ARHGEF3 Gene in Postmenopausal Osteoporosis The American Journal of Human Genetics, Volume 82, Issue 6, 6 June 2008, Pages 1262-1269 Ben H. Mullin, Richard L. Prince, Ian M. Dick, Deborah J. Hart, Tim D. Spector, Frank Dudbridge and Scott G. Wilson Abstract Osteoporosis is a common and debilitating bone disease characterized by low bone mineral density (BMD), a highly heritable and polygenic trait. Genome-wide linkage studies have identified 3p14-p21 as a quantitative trait locus for BMD. The ARHGEF3 gene is situated within this region and was identified as a strong positional candidate. The aim of this study was to evaluate the role of variation in ARHGEF3 on bone density in women. Sequence variation within ARHGEF3 was analyzed with 17 single-nucleotide polymorphisms (SNPs) in a discovery cohort of 769 female sibs. Significant associations were found with family-based association tests between five SNPs and various measures of age-adjusted BMD (p = 0.0007–0.041) with rs7646054 showing maximal association. Analysis of the data with QPDTPHASE suggested that the more common G allele at rs7646054 is associated with decreased age-adjusted BMD. Significant associations were also demonstrated between 3-SNP haplotypes and age-adjusted spine and femoral-neck BMD (p = 0.002 and 0.003, respectively). rs7646054 was then genotyped in a replication cohort, and significant associations with hip and spine BMD were confirmed (p = 0.003–0.038), as well as an association with fracture rate (p = 0.02). Again, the G allele was associated with a decrease in age-adjusted BMD at each site studied. In conclusion, genetic variation in ARHGEF3 plays a role in the determination of bone density in Caucasian women. This data implicates the RhoGTPase-RhoGEF pathway in osteoporosis. Abstract | | |